Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8839912 | Brain Research | 2018 | 23 Pages |
Abstract
The aim of the present study was to investigate the potential anxiolytic- and antidepressant-like actions of Urocortin 2 (Ucn2) and its two fragments, Ucn2 (1-21) and Ucn2 (22-38), in mice, in an attempt to identify the biologically active sequence of this 38 amino acid neuropeptide. In this purpose, male C57BL/6 mice were treated intracerebroventricularly (icv) with 0.125, 0.25, 0.5 and 1â¯Âµg/2â¯Âµl of Ucn2, Ucn2 (1-21) or Ucn2 (22-38). After 30â¯min, the mice were evaluated in an elevated plus-maze test and a forced swim test for anxiety- and depression-like behavior, respectively. Each test lasted 5â¯min. Ucn2 at dose of 0.25â¯Âµg/2â¯Âµl and Ucn2 (1-21) at dose of 0.125â¯Âµg/2â¯Âµl, but not Ucn2 (22-38), increased significantly the number of entries into and the time spent in the open-arms, without influencing the total number of entries. In parallel, the same doses of Ucn2 and Ucn2 (1-21), but not Ucn2 (22-38), increased significantly the climbing and the swimming activity, while decreasing significantly the time of immobility. In addition, Ucn2 at doses of 0.125â¯Âµg/2â¯Âµl and 0.5â¯Âµg/2â¯Âµl decreased significantly the time of immobility, but they did not change the other parameters. The present study demonstrates that Ucn2 exerts anxiolytic- and antidepressant-like effects in C57BL/6 mice, which are mediated by the N-terminal, but not the C-terminal fragment of the peptide. The establishment of the smallest active sequence by further fragmentation of Ucn2 (1-21) may allow the synthesis of new anxiolytic and antidepressant drugs.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Zsolt Bagosi, Krisztina Csabafi, Beáta Balangó, Dávid Pintér, Orsolya Szolomájer-Csikós, Zsolt Bozsó, Gábor Tóth, Gyula Telegdy, Gyula Szabó,